NEW DELHI: The total number of COVID-19 cases in India is nearing 20 crores. India has reported as many as 56,282 cases of COVID-19 in 24 hours, pushing the total tally to 19,64,536.
So far, the country has reported 5,95,501 active cases, 13,28,336 people have recovered and 40,699 people died.
Indian Council of Medical Research (ICMR) said that the total number of COVID-19 samples tested has reached 2.21 crore, out of which 6,64,949 samples were tested on July 5th.
Saddened by the tragic hospital fire in Ahmedabad. Condolences to the bereaved families. May the injured recover soon. Spoke to CM @vijayrupanibjp Ji and Mayor @ibijalpatel Ji regarding the situation. Administration is providing all possible assistance to the affected.— Narendra Modi (@narendramodi) August 6, 2020
A fire broke out in COVID-19 hospital in Ahmedabad, Gujarat, killing eight patients.
Regarding the fire, Chief Minister Vijay Rupani has ordered an investigation that will be led by the Additional chief secretary (home department) Sangeeta Singh.
In Karnataka, Medical Education Minister Dr Sudhakar inaugurated a first of its kind and reportedly the country’s only ICMR-approved mobile RT-PCR (reverse transcription-polymerase chain reaction) mobile lab in Bengaluru.
Globally, there are 1,88,09,199 cases of COVID-19 and out of that, 67,47,115 are active cases, 1,13,54,419 people have recovered and 7,07,665 people died.
US Centers for Disease Control and Prevention (CDC) into an outbreak at a summer camp in Georgia suggests children, highlighting risk related to the reopening of schools.
US President Donald Trump faced heat for spreading misinformation about COVID-19. He claimed in a Facebook post that children were “almost immune” to COVID-19. His argument comes amidst his demands to have all schools reopen and sent kids to study.
For the development of the COVID-19 vaccine, Novavax Inc said that it has entered a supply and license agreement with the Serum Institute of India.
Anthony Fauci, the top US infectious diseases official, said that suitable vaccine candidates will be ready by next year.